First-line treatment of advanced breast cancer with sunitinib in combination with docetaxel versus docetaxel alone: Results of a prospective, randomized phase III study

by Bergh, J., Bondarenko, I., Lichinitser, M., Liljegren, A., Greil, R., Voytko, N., Makhson, A., Cortes, J., Lortholary, A., Bischoff, J., Chan, Arlene, Delaloge, S., Huang, X., Kern, K., Giorgetti, C.
Published 2012